Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +44.45%
#2 Bitway Bitway +37.28%
#3 Pons Pons +37.06%
#4 Mubarak Mubarak +36.84%
#5 Ocean Protocol Ocean Protocol +34.14%
#6 Starpower Starpower +29.65%
#7 SkyAI SkyAI +21.90%
#8 Decred Decred +18.17%
#9 PondCoin PondCoin +18.16%
#10 TENDIES TENDIES +17.96%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
ABVC BioPharma, Inc. ABVC BioPharma, Inc.

ABVC BioPharma, Inc.

ABVC
Classifica tra le azioni #28867
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on... ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer. ABV-1504 has successfully completed Phase II clinical trials for major depressive disorders. ABV-1505 is progressing through Phase II clinical studies for attention deficit hyperactivity disorder (ADHD). ABV-1703 has concluded its Phase I clinical trials for the treatment of pancreatic cancer. ABV-1702 has also finished Phase I clinical investigations for myelodysplastic syndromes. ABV-1601 is in Phase I/II clinical trials, aimed at alleviating depression in individuals with cancer. ABV-1701 Vitargus is in development to treat conditions such as retinal detachment or vitreous hemorrhage. ABVC BioPharma maintains strategic alliances, including a co-development arrangement with Rgene Corporation, alongside collaborative agreements with BioHopeKing Corporation and BioFirst Corporation. The company's headquarters are located in Fremont, California, and it operates as a subsidiary of YuanGene Corporation.
Prezzo delle azioni
$0.9201
Capitalizzazione di mercato
$23.92M
Variazione (1 giorno)
6.23%
Variazione (1 anno)
-67.72%
Paese
US
Scambia ABVC BioPharma, Inc. (ABVC)

Categoria

Healthcare
Il prezzo ABVC con la capitalizzazione del mercato della B
ABVC BioPharma, Inc. ABVC BioPharma, Inc.
ABVC
$0.9201
Capitalizzazione di mercato di ABVC BioPharma, Inc.(ABVC)
Capitalizzazione di mercato: $23.92M
A partire dal August 2026, ABVC BioPharma, Inc. ha una capitalizzazione di mercato pari a $23.92M. Questo rende ABVC BioPharma, Inc. la 28867th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di ABVC BioPharma, Inc. dal 2004 al 2026
ABVC in paragone con la classifica dei più popolari stocks
Il prezzo per ABVC Attivo B Capitalizzazione del mercato a B Risultati
ABVC BioPharma, Inc. ABVC BioPharma, Inc.
$204,198 $23.92M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.309T +22,192,943.71%
ABVC BioPharma, Inc. ABVC BioPharma, Inc.
$179,270 $23.92M
Apple Inc. Apple Inc.
AAPL
$4.661T +19,483,680.21%
ABVC BioPharma, Inc. ABVC BioPharma, Inc.
$159,818 $23.92M
Alphabet Inc. Alphabet Inc.
GOOG
$4.155T +17,369,510.83%
ABVC BioPharma, Inc. ABVC BioPharma, Inc.
$138,350 $23.92M
Microsoft Corporation Microsoft Corporation
MSFT
$3.597T +15,036,301.45%
ABVC BioPharma, Inc. ABVC BioPharma, Inc.
$109,427 $23.92M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.845T +11,892,825.59%